Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
7 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Oragenics Inc.’s names, not what it holds today.
Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
17
2 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'06'07'09'10'11'12'14'15'16'18'20'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
Under which name2 counted
Oragenics, Inc its own name
US, as the owner printed on each patent
12 publishedOragenics, Inc. its own name
named as the applicant on its applications, in US
5 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Aug 4, 2020 | 10,729,157 | Methods for regulating weight and size of animals | Pharmaceuticals | Oragenics, Inc |
| May 8, 2018 | 9,963,488 | Variants of the lantibiotic MU1140 and other lantibiotics with improved pharmacological properties and structural features | Pharmaceuticals | Oragenics, Inc |
| Feb 16, 2016 | 9,260,488 | Replacement therapy for dental caries | Pharmaceuticals | Oragenics, Inc |
| Oct 21, 2014 | 8,865,156 | Compositions and methods for the maintenance of oral health | Pharmaceuticals | Oragenics, Inc |
| Oct 11, 2011 | 8,034,571 | Microbial polynucleotides expressed during infection of a host | Biotechnology | Oragenics, Inc |
| Apr 26, 2011 | 7,931,892 | Compositions and methods for the maintenance of oral health | Pharmaceuticals | Oragenics, Inc |
| Apr 21, 2009 | 7,521,529 | Differentially protected orthogonal lanthionine technology | Biotechnology | Oragenics, Inc |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jun 26, 2025 | 2025/0206774 | C-20 STEROID COMPOUNDS, COMPOSITIONS AND USES THEREOF TO TREAT TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSIONS | Organic fine chemistry | Oragenics, Inc. |
| Jan 2, 2025 | 2025/0001107 | BREATH-POWERED NASAL DEVICES FOR TREATMENT OF TRAUMATIC BRAIN INJURY (TBI), INCLUDING CONCUSSION, AND METHODS | Medical technology | Oragenics, Inc. |
| Dec 12, 2024 | 2024/0409576 | -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions- | Organic fine chemistry | Oragenics, Inc |
| May 7, 2015 | 2015/0125503 | Variants of the Lantibiotic MU1140 and Other Lantibiotics with Improved Pharmacological Properties and Structural Features | Pharmaceuticals | Oragenics, Inc. · patent 9,963,488 granted from it |
| Feb 19, 2015 | 2015/0050221 | Compositions and Methods for the Maintenance of Oral Health | Pharmaceuticals | Oragenics, Inc. · patent 9,962,330 granted from it |
| Feb 12, 2015 | 2015/0044146 | Replacement Therapy for Dental Caries | Pharmaceuticals | Oragenics, Inc. · patent 9,260,488 granted from it |
| May 24, 2012 | 2012/0128644 | Use of Bacteria to Treat and Prevent Respiratory Infections | Pharmaceuticals | Oragenics, Inc |
| May 17, 2012 | 2012/0122984 | Methods of Treating Lipomas and Liposarcomas | Pharmaceuticals | Oragenics, Inc |
| Jun 23, 2011 | 2011/0151490 | Compositions for the Detection and Treatment of Colorectal Cancer | Pharmaceuticals | Oragenics, Inc |
| May 26, 2011 | 2011/0123461 | Compositions and Methods for the Maintenance of Oral Health | Pharmaceuticals | Oragenics, Inc · patent 8,865,156 granted from it |
What it applied for, 2024 to 2025: Organic fine chemistry 2 · Medical technology 1.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.